Organization
Arthritis Innovation Corporation
2 clinical trials
Clinical trial
An Open Label Safety Study of a Single Administration of F14 in Patients Undergoing Unilateral Total Knee ReplacementStatus: , Estimated PCD: 2025-09-01
Clinical trial
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel Group Study of the Efficacy and Safety of a Single Administration of F14 for Postoperative Analgesia in Patients Undergoing Unilateral Total Knee ReplacementStatus: Active (not recruiting), Estimated PCD: 2023-11-22